We are live on ! Find out more
MIST icon

Milestone Pharmaceuticals
MIST

31 hedge funds and large institutions have $111M invested in Milestone Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

201% more capital invested

Capital invested by funds: $36.9M → $111M (+$74.2M)

117% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 6

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

29% more funds holding

Funds holding: 24 → 31 (+7)

23.06% more ownership

Funds ownership: 39.6% → 62.66% (+23%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $523K

Holders
31
Holders Change
+7
Holders Change %
+29.17%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
13
Increased
6
Reduced
3
Closed
6
Calls
–
Puts
$523K
Net Calls
-$523K
Net Calls Change
-$523K

Top Buyers

1
RCM
RA Capital Management
Massachusetts
+$17.3M
2
IC
Ikarian Capital
Texas
+$12.5M
3
BC
Boxer Capital
California
+$4.84M
4
O
OrbiMed
New York
+$2.77M
5
Millennium Management
Millennium Management
New York
+$2.21M

Top Sellers

1
KPF
K2 Principal Fund
Ontario, Canada
-$642K
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$455K
3
SSA
Schonfeld Strategic Advisors
New York
-$125K
4
SAMH
Shanda Asset Management Holdings
British Virgin Islands
-$98K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$79K
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
1
RTW Investments
New York
$31.6M – – –
RCM
2
RA Capital Management
Massachusetts
$17.7M +$17.3M +2,418,798 New
NHAS
3
Novo Holdings A/S
Denmark
$15.2M – – –
BC
4
Boxer Capital
California
$13M +$4.84M +675,000 +61%
IC
5
Ikarian Capital
Texas
$12.8M +$12.5M +1,743,545 New
Morgan Stanley
6
Morgan Stanley
New York
$5.32M +$923K +128,850 +22%
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$4.22M -$455K -63,483 -10%
O
8
OrbiMed
New York
$2.82M +$2.77M +385,791 New
Invesco
9
Invesco
Georgia
$2.31M -$35.6K -4,973 -2%
TCM
10
Tekla Capital Management
Massachusetts
$1.56M – – –
BFM
11
Boothbay Fund Management
New York
$1.46M +$1.08M +150,908 +316%
PVI
12
Pura Vida Investments
New York
$732K +$717K +100,000 New
SFI
13
Susquehanna Fundamental Investments
Pennsylvania
$623K +$324K +45,255 +113%
California Public Employees Retirement System
14
California Public Employees Retirement System
California
$375K +$139K +19,400 +61%
Barclays
15
Barclays
United Kingdom
$273K – – –
TD Asset Management
16
TD Asset Management
Ontario, Canada
$169K – – –
Two Sigma Investments
17
Two Sigma Investments
New York
$146K +$143K +19,902 New
State Street
18
State Street
Massachusetts
$129K +$126K +17,562 New
UBS Group
19
UBS Group
Switzerland
$121K +$21.9K +3,061 +23%
Renaissance Technologies
20
Renaissance Technologies
New York
$111K +$108K +15,100 New
FDCDDQ
21
Federation des caisses Desjardins du Quebec
Quebec, Canada
$95K – – –
Geode Capital Management
22
Geode Capital Management
Massachusetts
$93K – – –
CAC
23
Cowen and Company
New York
$88K +$85.9K +11,990 New
Goldman Sachs
24
Goldman Sachs
New York
$88K +$86K +12,004 New
SM
25
SG3 Management
Puerto Rico
$37K +$35.8K +5,000 New
1
2

MIST Hedge Fund Activity: Q3 2020 in Review

31 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Milestone Pharmaceuticals (MIST) for Q3 2020, worth a combined $111M — up 201% from $36.9M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new MIST positions and 6 closed out — a net gain of 7 holders — while 6 added to existing stakes and 3 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $17.3M. The largest seller was K2 Principal Fund, exiting entirely with an estimated $642K sold.

  • 31 institutional investors held Milestone Pharmaceuticals (MIST) as of Q3 2020, up from 24 in Q2 2020.
  • Funds reported $111M of Milestone Pharmaceuticals stock for Q3 2020, up 201% quarter-over-quarter.
  • 13 funds opened new Milestone Pharmaceuticals positions in Q3 2020 and 6 closed out, a net change of +7 holders.
  • The largest Milestone Pharmaceuticals buyer in Q3 2020 was RA Capital Management, an estimated $17.3M added.
  • The largest Milestone Pharmaceuticals seller in Q3 2020 was K2 Principal Fund, an estimated $642K sold.

Based on aggregated 13F filings for Q3 2020.